Prevalence rates of metabolic health and body size phenotypes by different criteria and association with insulin resistance in a Maltese Caucasian population.
Body Mass Index (BMI)
HOMA-IR
Insulin Resistance
Metabolic Health
Journal
BMC endocrine disorders
ISSN: 1472-6823
Titre abrégé: BMC Endocr Disord
Pays: England
ID NLM: 101088676
Informations de publication
Date de publication:
15 Jun 2022
15 Jun 2022
Historique:
received:
11
02
2022
accepted:
26
05
2022
entrez:
15
6
2022
pubmed:
16
6
2022
medline:
18
6
2022
Statut:
epublish
Résumé
Hyperinsulinemia and insulin resistance are known to be associated with increased cardiovascular morbidity and mortality. A metabolically unhealthy phenotype is frequently used as a surrogate marker for insulin resistance. The aims of the current study were to compare the prevalence of the body size phenotypes using different definitions of metabolic health and to investigate which one of them is most strongly associated with insulin resistance in men and women. We conducted a cross-sectional study in a middle-aged cohort of Maltese Caucasian non-institutionalized population. Metabolic health was defined using the various currently used definitions. There were significant differences in the prevalence of body size phenotypes according to the different definitions. We also found significant sex differences in the predictive value of the various definitions of the metabolically unhealthy phenotype to predict insulin resistance. The strongest association was for the definition of having >2 NCEP-ATPIII criteria to characterize the metabolic unhealthy phenotype in women (odds ratio of 19.7). On the other hand, the Aguilar-Salinas et al. definition had the strongest association in men (odds ratio of 18.7). We found large differences in the prevalence of the various body size phenotypes when using different definitions, highlighting the need for having standard criteria. Our data also suggest the need for sex-specific definitions of metabolic health.
Identifiants
pubmed: 35706017
doi: 10.1186/s12902-022-01071-x
pii: 10.1186/s12902-022-01071-x
pmc: PMC9199253
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
160Informations de copyright
© 2022. The Author(s).
Références
J Clin Endocrinol Metab. 2006 Aug;91(8):2906-12
pubmed: 16735483
Obesity (Silver Spring). 2009 Mar;17(3):601-5
pubmed: 19238145
Diabetes Care. 1991 Jun;14(6):461-9
pubmed: 1864219
J Clin Invest. 2019 Oct 1;129(10):3990-4000
pubmed: 31573548
Front Endocrinol (Lausanne). 2020 Feb 07;11:27
pubmed: 32117055
Diabetologia. 2004 Jul;47(7):1245-1256
pubmed: 15241592
Can J Public Health. 2022 Jun;113(3):484-500
pubmed: 35006592
Obesity (Silver Spring). 2006 Nov;14(11):2107-17
pubmed: 17135629
J Clin Endocrinol Metab. 2012 Jul;97(7):2482-8
pubmed: 22508708
Acta Diabetol. 2012 Dec;49(6):421-8
pubmed: 22215126
J Clin Lipidol. 2015 May-Jun;9(3):334-42
pubmed: 26073391
Hypertens Res. 2021 Dec;44(12):1617-1624
pubmed: 34599293
J Natl Cancer Inst. 2020 Feb 1;112(2):170-178
pubmed: 31184362
Diabetes Care. 2000 Jan;23(1):57-63
pubmed: 10857969
Behav Res Methods. 2009 Nov;41(4):1149-60
pubmed: 19897823
Eur J Clin Nutr. 2010 Oct;64(10):1043-51
pubmed: 20628408
JAMA. 2013 Jan 2;309(1):71-82
pubmed: 23280227
Med Sci (Basel). 2021 May 24;9(2):
pubmed: 34074048
Diabetes Care. 2000 Aug;23(8):1097-102
pubmed: 10937504
Diabetes Care. 2011 Jan;34(1):210-5
pubmed: 20937689
Arch Intern Med. 2008 Aug 11;168(15):1617-24
pubmed: 18695075
Int J Environ Res Public Health. 2021 Oct 25;18(21):
pubmed: 34769711
J Obes. 2012;2012:460321
pubmed: 23304462
Diabetes. 2007 Jun;56(6):1680-5
pubmed: 17363740
Diabetes Care. 2009 Dec;32(12):2297-9
pubmed: 19729521
Int J Clin Pract. 2021 Dec;75(12):e14969
pubmed: 34626508
Ann Epidemiol. 2004 Feb;14(2):101-8
pubmed: 15018882
Diabetes Metab. 2004 Dec;30(6):569-72
pubmed: 15671927
Br J Hosp Med (Lond). 2019 Aug 2;80(8):466-471
pubmed: 31437054
J Clin Endocrinol Metab. 2013 Oct;98(10):E1610-9
pubmed: 23979951
J Diabetes Res. 2017;2017:9294038
pubmed: 28840131
Eur J Prev Cardiol. 2015 Jul;22(7):940-9
pubmed: 24879358
Obesity (Silver Spring). 2019 Feb;27(2):309-314
pubmed: 30677260
Circulation. 1996 Apr 1;93(7):1372-9
pubmed: 8641026
J Am Coll Cardiol. 2018 Sep 25;72(13):1506-1531
pubmed: 30236314
J Nutr Sci. 2021 Sep 24;10:e81
pubmed: 34616552
Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S439-S444
pubmed: 28404516
J Clin Endocrinol Metab. 2008 Oct;93(10):4075-9
pubmed: 18682512
Obes Facts. 2019;12(1):78-90
pubmed: 30814477
J Endocrinol Metab. 2012 Apr 1;2(2):51-65
pubmed: 23293696
N Engl J Med. 2001 Jan 4;344(1):3-10
pubmed: 11136953
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
Medicine (Baltimore). 2016 Apr;95(15):e3384
pubmed: 27082607
Diabetes Metab Syndr. 2016 Apr-Jun;10(2 Suppl 1):S96-S101
pubmed: 27131406
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825